ELOC and renal cell carcinoma: In addition, ccRCC with wild-type VHL and TCEB1 mutations has been reported as an aggressive metastatic entity characterised by a sarcomatoid differentiation [43] thus manifesting an opposed behaviour to RCC-FMS, with which it shares molecular mutations, but not the prognosis.